Cash · 2011–2025
Halozyme Therapeutics cash
$134M+15.5% · FY2025
Halozyme Therapeutics (HALO) reported $134M in cash for fiscal 2025, +15.5% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $134M | +15.5% | Open → |
| FY20242024-12-31 | $116M | −2.1% | Open → |
| FY20232023-12-31 | $118M | −49.5% | Open → |
| FY20222022-12-31 | $234M | +97.3% | Open → |
| FY20212021-12-31 | $119M | −19.6% | Open → |
| FY20202020-12-31 | $148M | +22.9% | Open → |
| FY20192019-12-31 | $120M | +107.4% | Open → |
| FY20182018-12-31 | $57.9M | −65.7% | Open → |
| FY20172017-12-31 | $169M | +152.7% | Open → |
| FY20162016-12-31 | $66.8M | +54.2% | Open → |
| FY20152015-12-31 | $43.3M | −29.5% | Open → |
| FY20142014-12-31 | $61.4M | +124.4% | Open → |
| FY20132013-12-31 | $27.4M | −72.5% | Open → |
| FY20122012-12-31 | $99.5M | +90.0% | Open → |
| FY20112011-12-31 | $52.4M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +6.9%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Halozyme Therapeutics cash |url=https://companiesranked.com/en/company/halozyme-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Halozyme Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/halozyme-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-halozyme-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Halozyme Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/halozyme-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001159036-26-000104 · August 6, 2026
{{cite web |title=Halozyme Therapeutics cash — 10-Q (0001159036-26-000104) |url=https://www.sec.gov/Archives/edgar/data/1159036/000115903626000104/halo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.